HUM
Income statement / Annual
Last year (2023), Humana Inc.'s total revenue was $106.37 B,
an increase of 14.54% from the previous year.
In 2023, Humana Inc.'s net income was $2.49 B.
See Humana Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$106.37 B
|
$92.87 B
|
$83.06 B
|
$77.16 B
|
$64.89 B
|
$56.91 B
|
$53.77 B
|
$54.38 B
|
$54.29 B
|
$48.50 B
|
Cost of Revenue |
$13.19 B |
$12.67 B |
$10.12 B |
$10.05 B |
$7.38 B |
$7.53 B |
$6.57 B |
$7.28 B |
$7.32 B |
$7.64 B |
Gross Profit |
$93.19 B |
$80.20 B |
$72.94 B |
$67.10 B |
$57.51 B |
$49.39 B |
$47.20 B |
$47.10 B |
$46.97 B |
$40.86 B |
Gross Profit Ratio |
0.88 |
0.86 |
0.88 |
0.87 |
0.89 |
0.87 |
0.88 |
0.87 |
0.87 |
0.84 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$0.00
|
$12.20 B
|
$10.12 B
|
$10.05 B
|
$7.38 B
|
$7.53 B
|
$6.42 B
|
$7.17 B
|
$7.30 B
|
$7.64 B
|
Other Expenses |
$102.36 B |
$76.87 B |
$69.20 B |
$62.15 B |
$53.80 B |
$47.10 B |
$43.09 B |
$45.47 B |
$44.38 B |
$38.50 B |
Operating Expenses |
$102.36 B |
$89.07 B |
$79.32 B |
$72.20 B |
$61.18 B |
$54.62 B |
$49.51 B |
$52.64 B |
$51.67 B |
$46.14 B |
Cost And Expenses |
$102.36 B |
$89.07 B |
$79.32 B |
$72.20 B |
$61.18 B |
$54.62 B |
$49.51 B |
$52.64 B |
$51.67 B |
$46.14 B |
Interest Income |
$0.00 |
$401.00 M |
$326.00 M |
$283.00 M |
$242.00 M |
$218.00 M |
$242.00 M |
$189.00 M |
$186.00 M |
$192.00 M |
Interest Expense |
$493.00 M |
$401.00 M |
$326.00 M |
$283.00 M |
$242.00 M |
$218.00 M |
$242.00 M |
$189.00 M |
$186.00 M |
$192.00 M |
Depreciation &
Amortization |
$917.00 M
|
$845.00 M
|
$713.00 M
|
$616.00 M
|
$575.00 M
|
$534.00 M
|
$485.00 M
|
$465.00 M
|
$447.00 M
|
$449.00 M
|
EBITDA |
$4.93 B
|
$4.68 B
|
$4.34 B
|
$5.45 B
|
$4.17 B
|
$2.85 B
|
$4.75 B
|
$2.21 B
|
$3.06 B
|
$2.81 B
|
EBITDA Ratio |
0.05 |
0.05 |
0.05 |
0.07 |
0.07 |
0.05 |
0.09 |
0.04 |
0.06 |
0.06 |
Operating Income Ratio
|
0.04
|
0.04
|
0.05
|
0.06
|
0.06
|
0.04
|
0.08
|
0.03
|
0.05
|
0.05
|
Total Other
Income/Expenses Net |
-$630.00 M
|
-$232.00 M
|
-$391.00 M
|
-$386.00 M
|
$264.00 M
|
-$1.04 B
|
-$242.00 M
|
-$189.00 M
|
$84.00 M
|
-$192.00 M
|
Income Before Tax |
$3.38 B |
$3.57 B |
$3.35 B |
$4.60 B |
$3.46 B |
$2.06 B |
$4.02 B |
$1.55 B |
$2.43 B |
$2.17 B |
Income Before Tax Ratio
|
0.03
|
0.04
|
0.04
|
0.06
|
0.05
|
0.04
|
0.07
|
0.03
|
0.04
|
0.04
|
Income Tax Expense |
$836.00 M |
$762.00 M |
$485.00 M |
$1.31 B |
$763.00 M |
$391.00 M |
$1.57 B |
$938.00 M |
$1.16 B |
$1.02 B |
Net Income |
$2.49 B |
$2.81 B |
$2.93 B |
$3.37 B |
$2.71 B |
$1.68 B |
$2.45 B |
$614.00 M |
$1.28 B |
$1.15 B |
Net Income Ratio |
0.02 |
0.03 |
0.04 |
0.04 |
0.04 |
0.03 |
0.05 |
0.01 |
0.02 |
0.02 |
EPS |
20.09 |
22.2 |
22.79 |
25.47 |
20.2 |
12.24 |
16.94 |
4.11 |
8.54 |
7.44 |
EPS Diluted |
20 |
22.08 |
22.67 |
25.31 |
20.1 |
12.16 |
16.81 |
4.07 |
8.44 |
7.36 |
Weighted Average Shares
Out |
$123.87 M
|
$126.42 M
|
$128.69 M
|
$132.20 M
|
$134.05 M
|
$137.49 M
|
$144.49 M
|
$149.37 M
|
$149.45 M
|
$154.19 M
|
Weighted Average Shares
Out Diluted |
$124.44 M
|
$127.09 M
|
$129.40 M
|
$133.01 M
|
$134.73 M
|
$138.40 M
|
$145.58 M
|
$150.92 M
|
$151.14 M
|
$155.87 M
|
Link |
|
|
|
|
|
|
|
|
|
|